Early adverse events and patient-reported outcomes after salvage radiotherapy following prostatectomy according to fractionation schedule: Interim analysis of the phase III URONCOR 06–24 trial

Simple item page
dc.contributor.authorCouñago Lorenzo, Felipe
dc.contributor.authorGonzález, Carmen
dc.contributor.authorGómez Iturriaga, Alfonso
dc.contributor.authorÁlvarez, Ana
dc.contributor.authorSantos, Marina
dc.contributor.authorBoladeras-Inglada, A. M.
dc.contributor.authorGarcía, Nagore
dc.contributor.authorFernández, Sandra
dc.contributor.authorGonsalves, Daniela
dc.contributor.authorDuque Santana, Víctor
dc.contributor.authorEt.al.
dc.date.accessioned2026-10-05T08:03:17Z
dc.date.available2026-10-05T08:03:17Z
dc.date.issued2026
dc.description.abstractModerate hypofractionation is increasingly used in salvage radiotherapy (SRT) after radical prostatectomy, although prospective data in the postoperative setting remain limited. We evaluated early adverse events and patient-reported outcomes (PROs) according to fractionation schedule within a prospective multicenter phase III trial.en
dc.description.filiationUEMspa
dc.description.impact3.6 Q1 JCR 2025
dc.description.impact1.248 Q1 SJR 2025
dc.description.impactNo data IDR 2024
dc.description.sponsorshipSin financiación
dc.identifier.citationCouñago, F., González, C., Gómez-Iturriaga, A., Álvarez, A., Santos, M., Boladeras, A., García, N., Fernández, S., Guardado, S., Ocanto, A., Gonsalves, D., Glaría, L., Castaño, A., Martín, P., Montezuma, L., Mera, A., Mases, J., Meca, G., Duque-Santana, V., … López-Campos, F. (2026). Early adverse events and patient-reported outcomes after salvage radiotherapy following prostatectomy according to fractionation schedule: Interim analysis of the phase III URONCOR 06–24 trial. Clinical and Translational Radiation Oncology, 61, 101276. https://doi.org/10.1016/j.ctro.2026.101276
dc.identifier.doi10.1016/j.ctro.2026.101276
dc.identifier.issn2405-6308
dc.identifier.urihttps://hdl.handle.net/11268/17458
dc.language.isoeng
dc.peerreviewedSi
dc.relation.publisherversionhttps://doi.org/10.1016/j.ctro.2026.101276
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.otherMedicina
dc.subject.otherNeoplasias de la Próstata
dc.subject.otherTerapia Recuperativa
dc.subject.otherEfectos Colaterales y Reacciones Adversas Relacionados con Medicamentos
dc.subject.sdgGoal 3: Ensure healthy lives and promote well-being for all at all ages
dc.subject.unescoCáncer
dc.subject.unescoHombre
dc.subject.unescoTratamiento médico
dc.titleEarly adverse events and patient-reported outcomes after salvage radiotherapy following prostatectomy according to fractionation schedule: Interim analysis of the phase III URONCOR 06–24 trialen
dc.typejournal article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublication2e374c15-a9f7-4137-99a8-6be419e2c462
relation.isAuthorOfPublication116a6d00-95bc-49e5-a381-df10a08fde7a
relation.isAuthorOfPublication.latestForDiscovery2e374c15-a9f7-4137-99a8-6be419e2c462

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Early adverse events.pdf
Size:
3.03 MB
Format:
Adobe Portable Document Format
Download

Collections

Área de Ciencias de la Salud